Latest News - Rosacea

Monday, October 16, 2017 | PracticalDermatology.com, Research and Publications, National Rosacea Society

National Rosacea Society Awards New Grants; Call for 2018 Proposals

The National Rosacea Society (NRS) awarded funding for three new studies, in addition to continuing support for three ongoing studies, as part of its research grants program. Dr. Benjamin Kaffenber…

Read the full story

Monday, September 11, 2017 | PracticalDermatology.com, Research and Publications, Galderma

Two Galderma Rosacea Therapies Work Well Together

Combined use of Galderma’s SOOLANTRA (ivermectin1% Cream) and Mirvaso (Brimonidine 0.33% Gel) pack a one-two punch against the erythema and inflammatory lesions of rosacea, the MirvasO Soolantra…

Read the full story

Wednesday, August 23, 2017 | PracticalDermatology.com, Product Launches and Updates

Colorescience Takes Aim at Rosacea with All Calm™ Clinical Redness Corrector

Colorescience® is introducing All Calm™ Clinical Redness Corrector. Available Colorescience.com, all Calm Clinical Redness Corrector helps neutralize redness with its subtle green un…

Read the full story

Friday, August 11, 2017 | PracticalDermatology.com, Research and Publications, National Rosacea Society

Researchers Close in on Cause of Inflammation in Rosacea

Once developed, therapies that block TRPV4 may help treat or prevent inflammation in patients with rosacea, according to new research funded by the National Rosacea Society (NRS). In earlier resear…

Read the full story

Wednesday, July 05, 2017 | PracticalDermatology.com, Research and Publications, Galderma

Study: Soolantra is Both Anti-Inflammatory and Anti-Demodex

A recently published study sought to find scientific rationale for the dual anti-inflammatory and anti-parasitic mode of action of topical ivermectin 1% cream (Soolantra) in patients with rosacea. …

Read the full story

Wednesday, May 24, 2017 | PracticalDermatology.com, Product Launches and Updates, Allergan

Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch RHOFADE

Emmy and Tony award-winning actress and singer Kristin Chenoweth is kicking off  Allergan’s Rhofade "Less Red, More You" campaign. Chenoweth, who has rosacea, will begin a nati…

Read the full story

Monday, May 15, 2017 | Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Johnson & Johnson, Neutrogena

CVS Pharmacy's New Long Live Skin Campaign Aims to Increase Awareness of Skin Health

CVS Pharmacy, the retail division of CVS Health, is rolling out a new multi-platform Long Live Skin campaign  to increase awareness about skin health, sun safety and proper skincare. The Long …

Read the full story

Monday, May 01, 2017 | PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates

Foamix Announces Additional Phase 3 Trial for FMX101 in Moderate to Severe Acne

Foamix Pharmaceuticals is launching an additional Phase 3 trial for FMX101 in moderate to severe acne, a topical minocycline treatment. If the results are positive, this new Phase 3 trial is expect…

Read the full story

Thursday, April 27, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com

ASA Honors Researchers At Annual Meeting of the Society for Investigative Dermatology

Richard Edelson, MD Chair and Professor, Department of Dermatology, Yale School of Medicine, took home the David Martin Carter Mentor Award from the American Skin Association at the Annual M…

Read the full story

Thursday, April 20, 2017 | PracticalDermatology.com, Research and Publications, National Rosacea Society

White (But Not Red) Wine Linked to Rosacea

White wine and liquor may increase rosacea risk, according to a new study in the Journal of the American Academy of Dermatology. It is widely held that red wine consumption is linked to rosa…

Read the full story

Wednesday, March 01, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Research and Publications

Skin Diseases Remain Major Cause of Disability

Skin diseases are the fourth leading cause of disability worldwide, according to the Global Burden of Disease 2013 Study which appears online in JAMA Dermatology. For the study, researchers estimat…

Read the full story

Wednesday, March 01, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Research and Publications, American Academy of Dermatology

AAD Launches SkinSerious Campaign

The American Academy of Dermatology is launching a new campaign to raise awareness of the breadth of serious skin diseases as well as the critical role dermatologists play in an era of team-based heal…

Read the full story

Thursday, January 19, 2017 | FDA Approval/Clearance, PracticalDermatology.com, Allergan

FDA Approves RHOFADE™ (Oxymetazoline Hydrochloride) Cream, 1% For Persistent Facial Erythema Associated With Rosacea

The FDA has approved Allergan's RHOFADE™ cream for the topical treatment of persistent facial erythema associated with rosacea in adults. Approval was based on two clinical studies that eval…

Read the full story

Wednesday, January 18, 2017 | Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com

First Patient Treated in Dermata Therapeutics Phase 2 Acne Rosacea Clinical Study

The first patient has been dosed in Dermata Therapeutics’s Phase 2 acne rosacea study of DMT210, a topical gel specifically developed to downregulate the proinflammatory cytokines in the skin re…

Read the full story

Wednesday, January 04, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Research and Publications

Study Examines Diversity in Dermatologic Clinical Trials

Dermatologic clinical trials within the United States reflect the growing diversity of the US population, but reporting of both sex and racial/ethnic diversity of research cohorts is still lacking, es…

Read the full story
Load More